Gender/Sex & CUD Remission

Phase

N/A

Condition

Follicular Lymphoma

Substance Abuse

Treatment

Cognitive Behavioral Therapy (CBT4CBT)

Clinical Study ID

NCT04964739

00110801

R01DA054617

Ages > 18
All Genders

Study Summary

Adults (ages 18+) who would like to reduce their cannabis use (N=224) will be enrolled in an 8-week treatment program. All participants will receive counseling (1 goals session with a therapist followed by 7 weekly computerized cognitive-behavioral therapy sessions). Detailed cannabis assessments (biological and self-report) will be conducted throughout treatment and at 1-, 2-, and 3-months post-treatment completion. Daily electronic diaries will be administered via text message to record detailed logs of cannabis use quantity and frequency. Salivary samples will be collected (and video observed) daily throughout treatment to analyze for progesterone.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Willingness to participate in a research study (otherwise, will be referred toappropriate clinical services if seeking clinical care).
Meet current (within last 30 days) DSM-5 criteria for cannabis use disorder.
Submit a positive urine cannabinoid test during screening.
Interested in treatment for cannabis use disorder.

Exclusion

Exclusion Criteria:

Significant or acutely unstable medical or psychiatric problems (i.e., psychosis,mania) that would contraindicate research procedures, interfere with safety,compromise data integrity, or preclude consistent study participation.
The presence of any substance use disorder requiring a higher level of care.
Significant risk of homicide or suicide.
Pregnant, trying to become pregnant, or breastfeeding.

Study Design